Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study history now shows a new revision tag v3.6.3 as the latest update. The previous revision v3.6.2 has been removed from the history, reflecting an update to the record's versioning.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2 in the footer, indicating a deployment/version update. This represents a metadata update related to the site's software version.SummaryDifference0.0%

- Check39 days agoChange DetectedRecruitment status updated to indicate no longer looking for participants. The study record revision was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check46 days agoChange DetectedThe record history updates to include revision v3.5.5 as the current version and removes revision v3.5.4 from the list, indicating a page-level version update.SummaryDifference0.0%

- Check67 days agoChange DetectedThe Record History now includes a new revision tag v3.5.4. The previous revision v3.5.3 is removed from the history list.SummaryDifference0.0%

- Check90 days agoChange DetectedThis update reflects a change to the site’s interface/version label (revision v3.5.3 instead of v3.5.2) without altering the underlying clinical trial record history content.SummaryDifference0.0%

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.